Notice2026-00094

Joint Biomedical Laboratory (BL) and Clinical Science (CS) Research and Development Services Scientific Merit Review Board, Notice of Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 7, 2026

Issuing agencies

Veterans Affairs Department

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 4 (Wednesday, January 7, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 4 (Wednesday, January 7, 2026)]
[Notices]
[Page 552]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-00094]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Joint Biomedical Laboratory (BL) and Clinical Science (CS) 
Research and Development Services Scientific Merit Review Board, Notice 
of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act, 5 U.S.C. Ch. 10, that a meeting of the 
Joint Biomedical Laboratory Research and Development (BLR&D) and 
Clinical Science Research and Development (CSR&D) Services Scientific 
Merit Review Board (Board) will be held January 13, 2026, from 3:00 
p.m.-5:00 p.m. Eastern Standard Time (EST), via Microsoft Teams. The 
meeting will be open to the public from 3:00 p.m.-3:30 p.m. EST. The 
remained of the meeting, from 3:30 p.m.-5:00 p.m. EST, will be closed 
to the public and used for scientific review and discussion, 
examination of, and reference to the research applications. Discussions 
will involve staff and consultant critiques of research proposals. 
Discussions will also cover the scientific merit of each proposal and 
the qualifications of the personnel conducting the studies, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy. Additionally, premature disclosure of research 
information could significantly obstruct implementation of proposed 
agency action regarding the research proposals. Therefore, portions of 
the Board meeting will be closed is in accordance with 5 U.S.C. 552b(c) 
(6) and (9)(B).
    The objective of the Board is to provide for the fair and equitable 
selection of the most meritorious research projects for support by VA 
research funds and to offer advice for research program officials on 
program priorities and policies. The ultimate objective of the Board is 
to ensure the high quality and mission relevance of VA's BL/CS Research 
and Development programs.
    Board members will advise the Directors of the BL/CS Research 
Services, as well as the Acting Chief Research and Development Officer, 
on the scientific and technical merit, mission relevance, and 
protection of human subjects of the proposals submitted to BL/CS. The 
Board does not consider grants, contracts, or other forms of extramural 
research.
    Members of the public may attend the open portion of the meeting 
from 3:00 p.m.-3:30 p.m. EST, via Microsoft Teams (in listen-only mode, 
as the time-limited agenda does not allow for public comment or 
presentations). To attend the open portion of the meeting, the public 
may dial the Microsoft Teams phone number 1-872-701-0185 and enter the 
meeting access code 354 407 531#.
    Written comments from members of the public should be sent to 
Michael R. Burgio, Ph.D., Designated Federal Officer, Office of 
Research and Development, Department of Veterans Affairs (14RD), 810 
Vermont Avenue NW, Washington, DC 20420, or to <a href="/cdn-cgi/l/email-protection#bef3d7ddd6dfdbd290fccbccd9d7d1fec8df90d9d1c8"><span class="__cf_email__" data-cfemail="6825010b00090d04462a1d1a0f0107281e09460f071e">[email&#160;protected]</span></a>, 
at least five (5) days before the meeting. The written public comments 
will be shared with the Board members. The public may not attend the 
closed portion of the meeting.

    Dated: January 5, 2026.
Jelessa M. Burney,
Federal Advisory Committee Management Officer.
[FR Doc. 2026-00094 Filed 1-6-26; 8:45 am]
BILLING CODE 8320-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on January 7, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.